1919 Investment Counsel’s Calumet Specialty Products CLMT Stock Holding History

1919 Investment Counsel’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.7M	Hold	207,500	–	–	0.12%	166
2014 Q2	$6.6M	Hold	207,500	–	–	0.13%	143
2014 Q1	$5.36M	Hold	207,500	–	–	0.11%	170
2013 Q4	$5.4M	Hold	207,500	–	–	0.11%	165
2013 Q3	$5.66M	Hold	207,500	–	–	0.13%	148
2013 Q2	$7.55M	Buy	+207,500	New	+$7.46M	0.18%	116

Other funds holding CLMT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

IMS

Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Corrado Advisors Ramsey, New Jersey $217M AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

1919 Investment Counsel's CLMT Position: Q3 2014 in Review

1919 Investment Counsel held its Calumet Specialty Products (CLMT) position steady in Q3 2014 at 207,500 shares worth $5.7M. The position accounts for 0.12% of the portfolio, ranked #166.

1919 Investment Counsel first reported a position in CLMT in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.55M in Q2 2013. 115 funds tracked by Wall St. Rank hold CLMT as of Q3 2014.

1919 Investment Counsel held 207,500 shares of Calumet Specialty Products worth $5.7M as of Q3 2014.
1919 Investment Counsel left its Calumet Specialty Products share count unchanged in Q3 2014.
Calumet Specialty Products made up 0.12% of 1919 Investment Counsel's portfolio in Q3 2014, its #166 holding.
1919 Investment Counsel first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Calumet Specialty Products position peaked at $7.55M in Q2 2013.
115 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.